10.1073/pnas.0712321105 Proc
For a broader look at peptide therapy economics, we maintain a separate complete 2026 guide to peptide therapy cost across all our protocols that covers GLP-1 medications, NAD+, and other peptide stacks beyond BPC-157
Common problem areas: Abdomen (Ozempic belly or hanging lower belly skin) Upper arms (bat wings) Inner and outer thighs Buttocks (flatter or sagging appearance) Neck and lower face (jowls, deflated cheeks) Stubborn fat persists : While overall and visceral fat reduce effectively, subcutaneous fat in hormonesensitive areas (such as the lower abdomen, flanks, and bra line) can remain resistant due to genetics and agerelated changes in fat distribution
There have also been reports of gallbladder disease, including cholelithiasis (gallstones) and cholecystitis, possibly related to rapid weight loss
10.1111/dom.14281 137 OPDIVO (2021)
Zepbound is FDA-approved for weight loss